Your browser doesn't support javascript.
loading
Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell microniches.
Lee, Amos C; Lee, Yongju; Choi, Ahyoun; Lee, Han-Byoel; Shin, Kyoungseob; Lee, Hyunho; Kim, Ji Young; Ryu, Han Suk; Kim, Hoe Suk; Ryu, Seung Yeon; Lee, Sangeun; Cheun, Jong-Ho; Yoo, Duck Kyun; Lee, Sumin; Choi, Hansol; Ryu, Taehoon; Yeom, Huiran; Kim, Namphil; Noh, Jinsung; Lee, Yonghee; Kim, Inyoung; Bae, Sangwook; Kim, Jinhyun; Lee, Wooseok; Kim, Okju; Jung, Yushin; Kim, Changhoe; Song, Seo Woo; Choi, Yeongjae; Chung, Junho; Kim, Byung Gee; Han, Wonshik; Kwon, Sunghoon.
Afiliação
  • Lee AC; Bio-MAX Institute, Seoul National University, Seoul, 08826, Republic of Korea.
  • Lee Y; Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Choi A; Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Lee HB; Department of Surgery, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
  • Shin K; Biomedical Research Institute, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
  • Lee H; Cancer Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.
  • Kim JY; Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Ryu HS; Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Kim HS; Biomedical Research Institute, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
  • Ryu SY; Cancer Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.
  • Lee S; Department of Pathology, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
  • Cheun JH; Biomedical Research Institute, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
  • Yoo DK; Biomedical Research Institute, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
  • Lee S; Cancer Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.
  • Choi H; Interdisciplinary Programs in Cancer Biology Major, Seoul National University Graduate School, Seoul, 03080, Republic of Korea.
  • Ryu T; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, 03080, Republic of Korea.
  • Yeom H; Biomedical Research Institute, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
  • Kim N; Cancer Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.
  • Noh J; Interdisciplinary Programs in Cancer Biology Major, Seoul National University Graduate School, Seoul, 03080, Republic of Korea.
  • Lee Y; Department of Surgery, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
  • Kim I; Department of Surgery, SMG-SNU Boramae Medical Center, Seoul, 03080, Republic of Korea.
  • Bae S; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
  • Kim J; Department of Biomedical Science, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
  • Lee W; Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Kim O; Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Jung Y; ATG LIfetech Inc, Seoul, 08507, Republic of Korea.
  • Kim C; Bio-MAX Institute, Seoul National University, Seoul, 08826, Republic of Korea.
  • Song SW; Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Choi Y; Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Chung J; Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
  • Kim BG; Artificial Intelligence Institute, Seoul National University, Seoul, 08826, Republic of Korea.
  • Han W; Bio-MAX Institute, Seoul National University, Seoul, 08826, Republic of Korea.
  • Kwon S; Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
Nat Commun ; 13(1): 2540, 2022 05 09.
Article em En | MEDLINE | ID: mdl-35534484
ABSTRACT
Epitranscriptomic features, such as single-base RNA editing, are sources of transcript diversity in cancer, but little is understood in terms of their spatial context in the tumour microenvironment. Here, we introduce spatial-histopathological examination-linked epitranscriptomics converged to transcriptomics with sequencing (Select-seq), which isolates regions of interest from immunofluorescence-stained tissue and obtains transcriptomic and epitranscriptomic data. With Select-seq, we analyse the cancer stem cell-like microniches in relation to the tumour microenvironment of triple-negative breast cancer patients. We identify alternative splice variants, perform complementarity-determining region analysis of infiltrating T cells and B cells, and assess adenosine-to-inosine base editing in tumour tissue sections. Especially, in triple-negative breast cancer microniches, adenosine-to-inosine editome specific to different microniche groups is identified.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenosina Desaminase / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenosina Desaminase / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2022 Tipo de documento: Article